ARNT and hepatocellular carcinoma: Herein, we describe the evaluation of selected compounds (1–15) (Table 1) as monofunctional enzymatic inducers measuring QR phase-II enzyme activity in an in vitro model using wild-type mouse hepatoma Hepa-1c1c7 and Arnt defective mutant BpRc1 cells [17,18].